2018
DOI: 10.1242/jcs.221747
|View full text |Cite
|
Sign up to set email alerts
|

Nε-lysine acetylation in the endoplasmic reticulum – a novel cellular mechanism that regulates proteostasis and autophagy

Abstract: Protein post-translational modifications (PTMs) take many shapes, have many effects and are necessary for cellular homeostasis. One of these PTMs, Nε-lysine acetylation, was thought to occur only in the mitochondria, cytosol and nucleus, but this paradigm was challenged in the past decade with the discovery of lysine acetylation in the lumen of the endoplasmic reticulum (ER). This process is governed by the ER acetylation machinery: the cytosol:ER-lumen acetyl-CoA transporter AT-1 (also known as SLC33A1), and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
51
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 37 publications
(51 citation statements)
references
References 120 publications
0
51
0
Order By: Relevance
“…Mouse models of altered AT-1 expression are effective models of human AT-1-linked diseases 810 . Both cell-based and mouse-based experiments support the conclusion that AT-1 activity regulates ER proteostasis by maintaining the balance between quality control and the induction of reticulophagy 1,2,814 .…”
Section: Introductionmentioning
confidence: 73%
See 1 more Smart Citation
“…Mouse models of altered AT-1 expression are effective models of human AT-1-linked diseases 810 . Both cell-based and mouse-based experiments support the conclusion that AT-1 activity regulates ER proteostasis by maintaining the balance between quality control and the induction of reticulophagy 1,2,814 .…”
Section: Introductionmentioning
confidence: 73%
“…The acetyl-CoA transporter, AT-1 (also referred to as SLC33A1), is a key member of the endoplasmic reticulum (ER) acetylation machinery, transporting acetyl-CoA from the cytosol into the ER lumen where acetyl-CoA serves as the acetyl-group donor for Nε-lysine acetylation 1,2 . Gene duplications in AT-1/SLC33A1 have been identified in patients with autistic-like features, intellectual disability, and dysmorphic features; heterozygous mutations in AT-1/SLC33A1 are associated with a familial form of spastic paraplegia, while homozygous mutations are associated with developmental delay and premature death 37 .…”
Section: Introductionmentioning
confidence: 99%
“…The effect of AT-1 deletion on pancreatic function contributes to a growing understanding of the significance of Nε-lysine acetylation in the ER on protein folding and ER stress responses. [15][16][17] Investigation of the ER acetylome in cultured cell models previously has identified proteins such as glucose-regulated protein 78 (aka BiP Q14…”
Section: Discussionmentioning
confidence: 99%
“…The effect of AT-1 deletion on pancreatic function contributes to a growing understanding of the significance of Nε-lysine acetylation in the ER on protein folding and ER stress responses (18,35,36). Investigation of the ER acetylome in cultured cell models identified proteins such as BiP, LAMP2, and cathepsin D as acetylation targets (37), all of which are critical for pancreatic acinar cell function (38)(39)(40)(41).…”
Section: Discussionmentioning
confidence: 99%
“…ER proteostasis is influenced in part by Nε-lysine acetylation of nascent proteins, a posttranslational modification that assists in protein stability and trafficking through the secretory pathway (18). This process is regulated by the ER acetyl-CoA transporter AT-1, which moves cytosolic acetyl-CoA into the ER lumen to be used as a substrate for resident acetyltransferases (19,20).…”
Section: Introductionmentioning
confidence: 99%